IP Library › Granted Patent US 9,993,612
Granted Patent B2
US 9,993,612 · App. 15/803,335 · Granted Jun 12, 2018

Method for facilitating intranasal guidance

Inventors: Christopher Linden (Vista, CA); Frank Debartola (Roswell, GA); Donald Geer (New Port Richey, FL); Kevin E. Sanford (Chalfont, PA); Daryl J. Clark (Drexel Hill, PA); Timothy M. Schweikert (West Chester, PA)
Assignee: JET MEDICAL, INC.
A61M25/0041A61B17/24A61M5/007A61M5/46A61M11/00A61M25/0045A61M25/0068A61M25/0097A61M25/01A61M25/0108A61M25/0662A61M25/09A61M2025/0008A61M2025/0046A61M2025/0062A61M2025/0073A61M2025/0681A61M2210/0618A61M2210/0681
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,993,612
App. No.
15/803,335
Granted
Jun 12, 2018
Kind
B2
Abstract

A method for visualization and/or administration of medication of and into the sphenopalatine/pterygopalatine recess of a patient is provided. The method includes providing a sphenocath and inserting a guidewire into the nostril of a patient to a target area proximate the sphenopalatine/pterygopalatine recess of the patient. The sphenocath is advanced over the guidewire and a catheter hub of the sphenocath is rotated relative to a sheath hub to conform to an anatomy of the patient's sphenopalatine/pterygopalatine recess, such that the distal end of the catheter tube is proximal to the target area. The sphenocath is then advanced relative to a sheath assembly so that the distal end of a sphenocath catheter tube extends from a sphenocath sheath tube distal end and bends along the guidewire. The guidewire is removed and contrast media, fluids, and/or medication is administered to the patient's sphenopalatine/pterygopalatine ganglion disposed within the sphenopalatine recess of the patient.

Claims (13)

1. A method for visualization and/or administration of medication of and into the sphenopalatine/pterygopalatine recess of a patient comprising:

providing a sphenocath including a sheath assembly having a sheath hub with a sheath tube extending therefrom with a lumen extending from a proximal end of the sheath hub to a distal end of the sheath tube, said sheath hub including a guide slot extending along a top surface thereof, said guide slot including an indicator member thereon, a catheter assembly including a catheter hub with a catheter tube having a pre-formed curvature extending therefrom, the catheter tube having a lumen therewithin, said catheter hub including a radially extending projection thereon, and

wherein the catheter assembly is configured to be inserted into the sheath assembly such that the radially extending projection on the catheter hub engages the guide slot to limit relative rotation between the hubs while permitting relative axial movement, said guide slot having a width larger than a width of the projection such that the catheter hub is configured to rotate relative to the sheath hub over a rotational range of approximately 10 degrees in each rotational direction such that the preformed curvature is always positioned away from the indicator member and a distal end of the catheter tube cannot be modified relative the sheath hub beyond the rotational range;

inserting a guidewire into a nostril of a patient to a target area proximate the sphenopalatine/pterygopalatine recess of the patient;

advancing the sphenocath over the guidewire and rotating the catheter hub relative to the sheath hub to conform to an anatomy of the patient's sphenopalatine/pterygopalatine recess, such that the distal end of the catheter tube is proximate the target area;

advancing the catheter assembly relative to the sheath assembly whereby the distal end of the catheter tube extends from the sheath tube distal end;

aligning the preformed curvature of the catheter tube distal end with the patient's sphenopalatine/pterygopalatine recess;

removing the guidewire; and

administering contrast media, fluids, and/or medication to the patient's sphenopalatine/pterygopalatine ganglion.

2. The method of claim 1 , wherein the sheath tube distal end includes a radiopaque mark and the step of advancing the sphenocath over the guidewire includes the use of x-ray or fluoroscopy.

3. The method of claim 1 , wherein the sheath tube includes a series of distance markings and the step of advancing the sphenocath over the guidewire includes advancement based on the distance markings.

4. The method of claim 1 wherein the distal end of the catheter tube includes a spraying tip and administering the contrast media, fluids, and/or medication to the patient's sphenopalatine/pterygopalatine ganglion is done through the spraying tip.

5. The method of claim 4 wherein said spraying tip includes a slotted passage or a plurality of small opening at a substantially closed end thereof.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2018
From: MEDICAL COMPONENTS, INC.
To: JET MEDICAL, INC.
Reel/Frame 047787/0344 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2018
From: LINDEN, CHRISTOPHER; DEBARTOLA, FRANK; GEER, DONALD; SANFORD, KEVIN; CLARK, DARYL
To: MEDICAL COMPONENTS INC.
Reel/Frame 047748/0945 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2018
From: SCHWEIKERT, TIMOTHY M.
To: JET MEDICAL, INC.
Reel/Frame 047748/0957 →
Continuity (4)
Continuation 15412377 · Jan 23, 2017
Division 14548860 · Nov 20, 2014
Provisional Application 61907328 · Nov 21, 2013
Related Publication 20180056035A1 · Mar 1, 2018